MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) saw a significant increase in short interest in May. As of May 29th, there was short interest totaling 93,123 shares, an increase of 171.5% from the May 14th total of 34,298 shares. Based on an average daily trading volume, of 106,498 shares, the short-interest ratio is currently 0.9 days.
MediPharm Labs Price Performance
Shares of OTCMKTS MEDIF traded up $0.00 on Friday, reaching $0.05. 14,386 shares of the company’s stock traded hands, compared to its average volume of 84,600. MediPharm Labs has a 12 month low of $0.04 and a 12 month high of $0.08. The business’s 50 day simple moving average is $0.06 and its two-hundred day simple moving average is $0.05.
About MediPharm Labs
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Recommended Stories
- Five stocks we like better than MediPharm Labs
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
